Promoting Physical Activity After Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Colon Cancer
Related studies linked through entity extraction aliases.
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating Isovorin in Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Performance of the Water-Enema Computed Tomography (WE-CT)
- Status
- UNKNOWN
- Phase
- NA
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
- Status
- UNKNOWN
- Phase
- N/A
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
- Status
- UNKNOWN
- Phase
- N/A
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
- Status
- TERMINATED
- Phase
- PHASE2
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
- Status
- TERMINATED
- Phase
- N/A
Evaluation of Stool Tagging for Improved Patient Compliance
- Status
- UNKNOWN
- Phase
- N/A
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2